In this article, we will discuss Durvalumab (Warnings-23). So, let’s get started.
Type 1 Diabetes Mellitus which can present with diabetic ketoacidosis: Monitor patients for hyperglycemia or other signs and symptoms of diabetes. Initiate treatment with insulin as clinically indicated. Withhold or permanently discontinue Durvalumab based on the severity.